Company intelligence / Profile preview

NeuroEars

Ownership: Private
Development stage: Commercial

Overview

NeuroEars is a healthcare technology/biotech company based in South Korea focused on developing innovative solutions for neurological diseases, particularly targeting symptoms such as dizziness and tinnitus. The company's vision emphasizes improving quality of life for patients with these conditions through convergence technologies[1]. No published clinical results are available.

Therapeutic areas: Neurology
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Drug pipeline

3 assets

Anna

Commercial

Indications: Vertigo, Dizziness

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on NeuroEars.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NeuroEars.

Explore the full profile